## 

## 

||**Page**|
|---|---|
|Trusteesreport|1-2|
|Statementoftrusteesresponsibilities|3|
|Independentauditor'sreport|4-7|
|Consolidatedstatementoffinancialactivities|8|
|Consolidatedbalancesheet|9|
|Balancesheet|10|
|Consolidatedstatementofcashflows|11|
|Notestotheaccounts|12-22|





## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 




## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

|||**2023**|**2022**|
|---|---|---|---|
||**Notes**|**£**|**£**|
|**Incomeandendowmentsfrom:**||||
|Fundraisingactivities|**3**|3,745,464|3,951,469|
|Investmentincome||20,822|375|
|Otherincome|**4**|300,000|-|
|**Totalincomeandendowments**||4,066,286|3,951,844|
|**Expenditureon:**||||
|Fundraisingactivities|**5**|3,375,484|3,710,801|
|Charitableactivities|**6**|135,330|65,034|
|**Totalresourcesexpended**||3,510,814|3,775,835|
|**Netincome/(expenditure)fortheyear/**||||
|**Netmovementinfunds**||555,472|176,009|
|Fundbalancesat1April2022||1,785,927|1,609,918|
|**Fundbalancesat31March2023**||2,341,399|1,785,927|
|Themovementsinfundsallrelatetounrestrictedfunds.||||





## 

## 

## 

|||**2023**||**2022**||
|---|---|---|---|---|---|
||**Notes**|||||
|**Fixedassets**||||||
|Tangibleassets|**10**||2,342||3,747|
|**Currentassets**||||||
|Debtors|**12**|460,100||273,428||
|Cashatbankandinhand||3,010,751||2,194,809||
|||3,470,851||2,468,237||
|**Creditors:amountsfallingduewithin**|**13**|||||
|**oneyear**||(1,131,794)||(686,057)||
|Netcurrentassets|||2,339,057||1,782,180|
|**Totalassetslesscurrentliabilities**|||2,341,399||1,785,927|
|**Incomefunds**||||||
|Unrestrictedfunds|||2,341,399||1,785,927|
||||2,341,399||1,785,927|





## 

## 

## 

|||**2023**|**2022**||
|---|---|---|---|---|
||**Notes**|**E**|**E**|**E**|
|**Fixedassets**|||||
|Investments||1||**1**|
|**Currentassets**|||||
|Debtors|**12**|303,300|21,579||
|Cashatbankandinhand||2,808,267|1,722,899||
|||3,111,567|1,744,478||
|**Creditors:amountsfallingduewithin**|**13**||||
|**oneyear**||(1,134,933)|(329,934)||
|Netcurrentassets||1,976,634||1,414,544|
|**Totalassetslesscurrentliabilities**||1,976,635||1,414,545|
|**Incomefunds**|||||
|Unrestrictedfunds||1,976,635||1,414,545|
|||1,976,635||1,414,545|
|TheaccountswereapprovedbytheTrusteeson||_ee_eiA410-er_1-01-3|||



## 



## 

## 

## 

|||**2023**|||**2022**||
|---|---|---|---|---|---|---|
||**Notes**|**£**|**£**|**£**||**£**|
|**Cashflowsfromoperatingactivities**|||||||
|Cashgeneratedfrom/(absorbedby)|**15**||||||
|operations|||515,942|||105,108|
|**Investingactivities**|||||||
|Proceedsondisposaloftangiblefixed|||||||
|assets||300,000|||||
|**Netcashgeneratedfrom/(usedin)**|||||||
|**investingactivities**|||300,000||||
|**Netcashusedinfinancingactivities**|||||||
|**Netincrease/(decrease)incashandcash**|||||||
|**equivalents**|||815,942|||105,108|
|Cashandcashequivalentsatbeginningof|year||2,194,809|||2,089,701|
|**Cashandcashequivalentsatendofyear**|||3,010,751|||2,194,809|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

|Depreciationisrecognisedsoastowriteoffthecostorvaluationofassetslesstheirresidualvaluesovertheir|Depreciationisrecognisedsoastowriteoffthecostorvaluationofassetslesstheirresidualvaluesovertheir|
|---|---|
|usefullivesonthefollowingbases:||
|Equipment|straightlineover4years|
|Medicalequipment|basedonspecialistexpertadvice|



## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

||**2023**|**2022**|
|---|---|---|
||**E**|**E**|
|PrivateHealthUniversityHospitalsDorsetLimitedturnover|3,396,710|3,696,759|
|Incomefromhireofequipment|6,000|36,000|
|Consumablesrecharged|342,754|218,710|
||3,745,464|3,951,469|





## 

## 

## 

## 

||**Unrestricted**|Total|
|---|---|---|
||**funds**||
||**2023**|2022|
||£|£|
|Netgainondisposaloftangiblefixedassets|300,000||
|**ConsolidatedexpenditureonFundraisingactivities**|||
||**2023**|**2022**|
||**£**|**£**|
|Purchases|3,203,176|3,314,477|
|Trainingcostsandsubsistence|7,702|4,880|
|Insurance|9,011|14,680|
|Telephone||8,407|
|Computersoftwareandmaintenance|5,685|4,140|
|Adminservices|33,365|31,238|
|Financialservices|62,597|65,072|
|Printing,postageandstationery|1,619|924|
|Subscriptions|28,879|12,438|
|Sundry|3,130|426|
|Advertising|10,380|600|
|Depreciation|1,405|59,025|
|Baddebtswrittenoff(includingmovementonprovisions)|8,535|167,234|
|Irrecoverabletaxesonfundraisingactivities|-|27,260|
||3,375,484|3,710,801|
|**Analysisbyfund**|||
|Unrestrictedfunds|3,375,484|3,710,801|



## 



## 

## 

## 

||**2023**|**2022**|
|---|---|---|
||**£**|**£**|
|GrantstoUniversityHospitalsDorsetNHSFoundationTrust:|||
|0317WardEquipment||12,970|
|Governancecosts:|||
|Auditfee|7,538|7,722|
|Bankcharges|17,732|12,572|
|Legalfees|110,060|31,770|
||135,330|65,034|



## 

|**8**|**Consolidatednetmovementinfunds**|**2023**|**2022**|
|---|---|---|---|
|||**£**|**£**|
||Netmovementinfundsisstatedaftercharging/(crediting)|||
||Feespayabletothecompany'sauditorfortheauditofthegroup'sfinancial|||
||statements|7,538|7,722|
||Depreciationofownedtangiblefixedassets|1,405|59,025|
||Profitondisposaloftangiblefixedassets|(300,000)|_|



## 



## 

## 

## 

|**10**|**Tangiblefixedassets**||
|---|---|---|
||**Group**|**Equipment**|
|||**£**|
||**Cost**||
||At1April2022|1,217,025|
||Disposals|(1,210,000)|
||At31March2023|7,025|
||**Depreciationandimpairment**||
||At1April2022|1,213,278|
||Depreciationchargedintheyear|1,405|
||Eliminatedinrespectofdisposals|(1,210,000)|
||At31March2023|4,683|
||**Carryingamount**||
||At31March2023|2,342|
||At31March2022|3,747|





## 

## 

## 

|**10**|**Tangiblefixedassets**|**(Continued)**|
|---|---|---|
||**Charity**|**Equipment**|
|||**£**|
||**Cost**||
||At1April2022|1,210,000|
||Disposals|(1,210,000)|
||At31March2023|-|
||**Depreciationandimpairment**||
||At1April2022|1,210,000|
||Depreciationchargedintheyear|_|
||Eliminatedinrespectofdisposals|(1,210,000)|
||At31March2023|_|
||**Carryingamount**||
||At31March2023||
||At31March2022||





## 

## 

||**2023**|**2022**|
|---|---|---|
||**£**|**£**|
|Turnover|3,396,710|3,696,759|
|Costofsales|(2,850,462)|(3,087,665)|
|Grossprofit|546,248|609,094|
|Administrativeexpenses|(304,749)|(359,722)|
|Netinterestreceivable|2,742|83|
|Interestpayableandsimilarcharges|-||
|Taxation||(27,260)|
|Netincomefortheyear|244,241|222,195|
|GiftAiddonation|(250,860)||
|Retainedprofit/(loss)fortheyear|(6,619)|222,195|
|Theaggregateofthenetassets,liabilitiesandfundswas:|||
||**2023**|**2022**|
||**£**|**£**|
|Tangiblefixedassets|2,342|3,747|
|Currentassets|362,583|744,978|
|Currentliabilities|(736,269)|(627,745)|
|Amountsowedfrom/(to)thecharity|736,109|250,403|
|Funds(representingoneordinaryshareof£1each)|1|1|
|Retainedprofit/(loss)|364,764|371,382|





## 

## 

## 

|**Debtors**|||||
|---|---|---|---|---|
||**Group**||**Charity**||
||**2023**|**2022**|**2023**|**2022**|
|**Amountsfallingduewithinoneyear:**|**£**|**£**|**£**|**£**|
|Tradedebtors|148,614|256,967||_|
|Amountsduefromrelatedparties|-||3,300|21,579|
|Otherdebtors|300,000||300,000||
|Prepaymentsandaccruedincome|11,486|16,461|-||
||460,100|273,428|303,300|21,579|



||**Group**||**Charity**||
|---|---|---|---|---|
||**2023**|**2022**|**2023**|**2022**|
||**£**|**£**|**£**|**£**|
|Tradecreditors|576,199|191,344|390,754|48,211|
|Amountsduetogroupundertakings|-||736,109|277,304|
|Amountsduetorelatedparties|486,368|325,348|-|-|
|Accrualsanddeferredincome|59,544|105,272|8,070|4,419|
|Othercreditors|9,683|64,093|-|-|
||1,131,794|686,057|1,134,933|329,934|



## 



## 

## 

## 

|**15**|**Consolidatedcashgeneratedfromoperations**|**2023**|**2022**|
|---|---|---|---|
||Surplus/(deficit)fortheyear|555,472|176,009|
||Adjustmentsfor:|||
||Depreciationandimpairmentoftangiblefixedassets||59,025|
||Gainondisposaloffixedasset|1,405||
||Movementsinworkingcapital:|(300,000)||
||(Increase)/Decreaseindebtors|(186,672)|79,116|
||Increase/(Decrease)increditors|445,737|(209,042)|
||**Cashgeneratedfrom/(absorbedby)operations**|515,942|105,108|